Live-cell Imaging Platform
Axion BioSystemsRequest Info
ATLANTA, Feb. 7, 2023 —
The Omni Pro 12 Live-Cell Imaging Platform from Axion BioSystems Inc. features integrated robotics and a multi-plate design compatible with any standard incubator for scientists and drug developers who desire flexibility and efficiency when conducting live-cell imaging experiments.
From label-free, long-term cell monitoring to fluorescence-based assays, live-cell imaging can be an integral tool to advance immunology, oncology, and stem cell biology, facilitating the development of novel drugs and therapeutics. The Omni Pro 12 uses high-capacity brightfield and fluorescence imaging to continuously assess cell behavior and function without sacrificing cell health and viability. Artificial intelligence-driven image analysis software minimizes subjectivity in the interpretation of data, allowing users to gain a quantitative assessment.
https://www.axionbiosystems.com
https://www.photonics.com/Buyers_Guide/Axion_BioSystems/c33376
Photonics.com
Feb 2023